Early research (Phase 1)Study completedNCT00002372What this trial is testing141W94 in Combination With Other Anti-HIV DrugsWho this might be right forHIV Infections Glaxo Wellcome 48
Not applicableNot Yet RecruitingNCT07663656What this trial is testingRobotic Bronchoscopy With CBCT Image Fusion for Pulmonary Nodule Diagnosis in People Living With HIVWho this might be right forHIV InfectionsPulmonary Nodule wu qingguo 100
Large-scale testing (Phase 3)Study completedNCT02369965What this trial is testingTest Albuvirtide in Experienced PatientsWho this might be right forHIV InfectionsAIDS Frontier Biotechnologies Inc. 418
Early research (Phase 1)UnknownNCT00006209What this trial is testingTucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV DrugsWho this might be right forHIV Infections Aaron Diamond AIDS Research Center 24
Testing effectiveness (Phase 2)Ended earlyNCT04493216What this trial is testingA Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive AdultsWho this might be right forHIV Infections ViiV Healthcare 161
Large-scale testing (Phase 3)Study completedNCT00000714What this trial is testingAn Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved TherapiesWho this might be right forPneumonia, Pneumocystis CariniiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT02824536What this trial is testing3BNC117 and 10-1074 in HIV Uninfected AdultsWho this might be right forHuman Immunodeficiency Virus Rockefeller University 24
Early research (Phase 1)Study completedNCT02489487What this trial is testingStudy in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500Who this might be right forHIV-infection Viriom 24
Large-scale testing (Phase 3)Study completedNCT00043888What this trial is testingStudy to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIRWho this might be right forHIV Infections GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT00001002What this trial is testingFoscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long TimeWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 12
Post-approval studies (Phase 4)Study completedNCT00615745What this trial is testingONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to AtriplaWho this might be right forHIV Infections Gilead Sciences 115
Large-scale testing (Phase 3)Ended earlyNCT01467479What this trial is testingTreat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)Who this might be right forHepatitis C Vertex Pharmaceuticals Incorporated 185
Large-scale testing (Phase 3)Study completedNCT00002122What this trial is testingStudy of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected PatientsWho this might be right forMycosesMycobacterium Avium-Intracellulare InfectionHIV Infections Pfizer 720
Testing effectiveness (Phase 2)Study completedNCT00001045What this trial is testingComparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT00000995What this trial is testingAZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) InfectionWho this might be right forCytomegalovirus InfectionsHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00736502What this trial is testingPMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.Who this might be right forHIV Infections Boehringer Ingelheim 280
Large-scale testing (Phase 3)Study completedNCT03227861What this trial is testingEvaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of CareWho this might be right forHIV-1 Janssen Scientific Affairs, LLC 109
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01852370What this trial is testingSequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency DiseasesWho this might be right forSevere Combined Immunodeficiency (SCID)Immunodeficiency With Predominant T-cell Defect, UnspecifiedSevere Chronic Neutropenia+6 more Paul Szabolcs 16
Large-scale testing (Phase 3)Study completedNCT00000903What this trial is testingAddition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment RegimenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 444
Not applicableStudy completedNCT00001102What this trial is testingThe Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 460